SCOPUS 정보 검색 플랫폼

Toxicologic Pathology

Volumn 27, Issue 1, 1999, Pages 1-3

Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use

(2) Klingbeil, Corine a Hsu, Di Hwei a

a PROTEIN DESIGN LABS INC (United States)

Author keywords

Anti CD3; Anti HLA DR; B cell; Chimpanzee; CRS; Cytokine release syndrome; IgG2; Immunogenicity; T cell

Indexed keywords

APOLIZUMAB; CD3 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUM291; OKT 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CHIMPANZEE; CONFERENCE PAPER; DRUG SAFETY; IMMUNOGENICITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

PAN TROGLODYTES; PRIMATES;

EID: 0032979346 PISSN: 01926233 EISSN: None Source Type: Journal
DOI: 10.1177/019262339902700101 Document Type: Conference Paper

Times cited : (32)

References (6)

1
- 0024554613
- Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
- Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, De Pauw L, Wybran J, Kinnaert P, Dupont E, and Toussaint C (1989). Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47: 606.
- (1989) Transplantation , vol.47 , pp. 606
- Abramowicz, D.¹ Schandene, L.² Goldman, M.³ Crusiaux, A.⁴ Vereerstraeten, P.⁵ De Pauw, L.⁶ Wybran, J.⁷ Kinnaert, P.⁸ Dupont, E.⁹ Toussaint, C.¹⁰

2
- 0031252326
- Human IgG2 variants of chimeric anti-CD3 are non-mitogenic to T cells
- Cole MS, Anasetti C, and Tso JY (1997). Human IgG2 variants of chimeric anti-CD3 are non-mitogenic to T cells. J. Immunol. 159: 3613-3621.
- (1997) J. Immunol. , vol.159 , pp. 3613-3621
- Cole, M.S.¹ Anasetti, C.² Tso, J.Y.³

3
- 0023038734
- OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies
- Goldstein G, Fuccello AJ, Norman DJ, Schield CE Colvin RB, and Cosimi AB (1986). OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies. Transplantation 42: 507-511.
- (1986) Transplantation , vol.42 , pp. 507-511
- Goldstein, G.¹ Fuccello, A.J.² Norman, D.J.³ Schield, C.E.⁴ Colvin, R.B.⁵ Cosimi, A.B.⁶

4
- 0028862395
- The OKT3 antibody response study: A multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation
- Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, and Wall W (1995). The OKT3 antibody response study: A multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation. Transplant. Immunol. 3: 212.
- (1995) Transplant. Immunol. , vol.3 , pp. 212
- Kimball, J.A.¹ Norman, D.J.² Shield, C.F.³ Schroeder, T.J.⁴ Lisi, P.⁵ Garovoy, M.⁶ O'Connell, J.B.⁷ Stuart, F.⁸ McDiarmid, S.V.⁹ Wall, W.¹⁰

5
- 1842368507
- IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
- Maloney DG, Grillo-López AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, and Levy R (1997). IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90: 2188-2195.
- (1997) Blood , vol.90 , pp. 2188-2195
- Maloney, D.G.¹ Grillo-López, A.J.² White, C.A.³ Bodkin, D.⁴ Schilder, R.J.⁵ Neidhart, J.A.⁶ Janakiraman, N.⁷ Foon, K.A.⁸ Liles, T.M.⁹ Dallaire, B.K.¹⁰ Wey, K.¹¹ Royston, I.¹² Davis, T.¹³ Levy, R.¹⁴

6
- 0029565168
- Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: Bibliographic review
- Sgro C (1995). Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: Bibliographic review. Toxicology 105: 23-29.
- (1995) Toxicology , vol.105 , pp. 23-29
- Sgro, C.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.